Quantum Biopharma (QNTM) FCF Payout Ratio (2019 - 2021)

Quantum Biopharma (QNTM) reported FCF Payout Ratio of 0.86 for Q3 2021, down 10.87% on a YoY basis from 0.96 in Q3 2020, and up 15.24% sequentially from 1.01 in Q2 2021.

Quantum Biopharma (QNTM) FCF Payout Ratio (2019 - 2021) Analysis & Trends

Quantum Biopharma (QNTM) has 3 years of FCF Payout Ratio data on file, last reported at 0.86 in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 0.12
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Quantum Biopharma 13.00 Bn 13.00 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2021 -0.86
Jun 30, 2021 -1.01
Mar 31, 2021 10.00
Sep 30, 2020 -0.77
Jun 30, 2020 -0.74
Mar 31, 2020 -1.52
Mar 31, 2019 3.81